Literature DB >> 35782019

Airspace Dimension Assessment with Nanoparticles (AiDA) in Comparison to Established Pulmonary Function Tests.

Madeleine Petersson-Sjögren1,2, Jonas Jakobsson3, H Laura Aaltonen4,5, Hanna Nicklasson6,7, Jenny Rissler1,2,8, Gunnar Engström9, Per Wollmer6, Jakob Löndahl1,2.   

Abstract

Background: Airspace Dimensions Assessment with nanoparticles (AiDA) is a new method for non-invasive measurement of pulmonary distal airspaces. The aim of this study was to compare AiDA measurements with other pulmonary function variables to better understand the potential of AiDA in a clinical context.
Methods: AiDA measurements and pulmonary function tests were performed in 695 subjects as part of the Swedish CArdioPulmonary bioImage Study. The measurement protocol included spirometry, measurement of diffusing capacity of carbon monoxide, oscillometry and pulmonary computed tomography. AiDA indices were compared to all other pulmonary examination measurements using multivariate statistical analysis.
Results: Our results show that AiDA measurements were significantly correlated with other pulmonary function examination indices, although covariance was low. We found that AiDA variables explained variance in the data that other lung function variables only influenced to a minor extent.
Conclusion: We conclude that the AiDA method provides information about the lung that is inaccessible with more conventional lung function techniques.
© 2022 Petersson-Sjögren et al.

Entities:  

Keywords:  COPD diagnostics; aerosol nanoparticles; airspace dimension assessment with nanoparticles; distal airspaces; respiratory diagnostics with nanoparticles

Mesh:

Substances:

Year:  2022        PMID: 35782019      PMCID: PMC9241766          DOI: 10.2147/IJN.S360271

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  47 in total

1.  Design and testing of Electrostatic Aerosol in Vitro Exposure System (EAVES): an alternative exposure system for particles.

Authors:  K de Bruijne; S Ebersviller; K G Sexton; S Lake; D Leith; R Goodman; J Jetters; G W Walters; M Doyle-Eisele; R Woodside; H E Jeffries; I Jaspers
Journal:  Inhal Toxicol       Date:  2009-02       Impact factor: 2.724

2.  Technical standards for respiratory oscillometry.

Authors:  Gregory G King; Jason Bates; Kenneth I Berger; Peter Calverley; Pedro L de Melo; Raffaele L Dellacà; Ramon Farré; Graham L Hall; Iulia Ioan; Charles G Irvin; David W Kaczka; David A Kaminsky; Hajime Kurosawa; Enrico Lombardi; Geoffrey N Maksym; François Marchal; Beno W Oppenheimer; Shannon J Simpson; Cindy Thamrin; Maarten van den Berge; Ellie Oostveen
Journal:  Eur Respir J       Date:  2020-02-27       Impact factor: 16.671

3.  Within-session reproducibility of forced oscillometry.

Authors:  Per Wollmer; Ellen Tufvesson; André Wennersten; Ulf Malmqvist; Gunnar Engström; Henric K Olsson; Suneela Zaigham; Sophia Frantz; Ulf Nihlén
Journal:  Clin Physiol Funct Imaging       Date:  2021-04-29       Impact factor: 2.273

4.  Pulmonary emphysema: objective quantification at multi-detector row CT--comparison with macroscopic and microscopic morphometry.

Authors:  Afarine Madani; Jacqueline Zanen; Viviane de Maertelaer; Pierre Alain Gevenois
Journal:  Radiology       Date:  2006-01-19       Impact factor: 11.105

5.  MR imaging of diffusion of (3)He gas in healthy and diseased lungs.

Authors:  B T Saam; D A Yablonskiy; V D Kodibagkar; J C Leawoods; D S Gierada; J D Cooper; S S Lefrak; M S Conradi
Journal:  Magn Reson Med       Date:  2000-08       Impact factor: 4.668

6.  Deposition of inhaled nanoparticles is reduced in subjects with COPD and correlates with the extent of emphysema: proof of concept for a novel diagnostic technique.

Authors:  H L Aaltonen; J K Jakobsson; S Diaz; S Zackrisson; E Piitulainen; J Löndahl; P Wollmer
Journal:  Clin Physiol Funct Imaging       Date:  2018-04-10       Impact factor: 2.273

Review 7.  Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective.

Authors: 
Journal:  Respirology       Date:  2005-01       Impact factor: 6.424

8.  Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Respir Med       Date:  2020-06       Impact factor: 30.700

9.  Airspace Dimension Assessment (AiDA) by inhaled nanoparticles: benchmarking with hyperpolarised 129Xe diffusion-weighted lung MRI.

Authors:  Madeleine Petersson-Sjögren; Ho-Fung Chan; Guilhem J Collier; Graham Norquay; Lars E Olsson; Per Wollmer; Jakob Löndahl; Jim M Wild
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

10.  Airspace dimension assessment with nanoparticles as a proposed biomarker for emphysema.

Authors:  H Laura Aaltonen; Madeleine Petersson Sjögren; Jonas K F Jakobsson; Hanna Nicklasson; Sandra Diaz; Francisco Sánchez Montiel; Sophia Zackrisson; Veronica Ideböhn; Gunnar Engström; Jakob Löndahl; Per Wollmer
Journal:  Thorax       Date:  2021-04-15       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.